Trial Profile

Use of Duloxetine or Pregabalin in Monotherapy versus Combination Therapy of Both Drugs in Patients with Painful Diabetic Neuropathy "The COMBO - DN (Combination vs Monotherapy of pregaBalin and dulOxetine in Diabetic Neuropathy) Study"

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 20 Jan 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

05 Oct 2012 Results from duloxetine monotherapy versus pregabalin monotherapy analysis presented at the 48th Annual Meeting of the European Association for the Study of Diabetes.
31 Aug 2012 Results presented at the 14th World Congress on Pain.
15 Mar 2012 This trial is recruting in England, Sweden, Spain, France as reported by European Clinical Trials Database.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com